STOCK TITAN

Integer Holdings completes $127-a-share cash merger

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Very High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Integer Holdings Corp. completed its merger with Armstrong Bidco, a subsidiary of Armstrong Parent, an affiliate of funds managed by KKR. Each outstanding common share, other than shares owned by Parent, Merger Sub or Parent subsidiaries, converted into a right to receive $127.00 in cash. The company reported approximately $5.4 billion in total merger consideration; the transaction announcement described enterprise value of approximately $5.7 billion. Integer became Parent’s wholly owned subsidiary, and trading in its shares was suspended before the market opened on November 17, 2026.

The new credit agreement provides for $2.1 billion in initial term loans and revolving loans of up to $350 million outstanding; Integer repaid and terminated its prior credit agreement at closing. Holders of the 2028 and 2030 convertible notes may convert through January 8, 2027. During the Make-Whole Fundamental Change Period, the stated cash conversion amounts are approximately $1,491.08 per $1,000 principal amount of 2028 notes and $1,029.25 per $1,000 of 2030 notes. Holders have no right to require repurchase in connection with the merger. Integer requested NYSE removal of its common shares.

1 point · 1 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 0 points

How the balance works

Positive

  • Major pointEligible shares converted to a right to receive $127.00 per share in the completed merger.

Negative

  • None.

Filing Explained

Integer’s terminated capped calls carry cash payments due from counterparties within one business day after closing.

At closing, the replacement credit facility’s obligations became guaranteed by Parent and certain subsidiaries and secured on a first-priority basis by substantially all assets of Integer and the guarantors, subject to exclusions.

Integer also terminated its 2028 and 2030 capped-call transactions at closing; the termination agreements provide for cash payments from the counterparties within one business day after closing.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 1.02 Termination of a Material Definitive Agreement Business
A significant contract was terminated, which may affect business operations or revenue.
Item 2.01 Completion of Acquisition or Disposition of Assets Financial
The company completed a significant acquisition or sale of business assets.
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities
The company received a delisting notice, failed to satisfy a continued-listing rule or standard, or transferred its listing.
Item 3.03 Material Modification to Rights of Security Holders Securities
A change was made that materially affects the rights of existing shareholders (e.g., dividend rights, voting rights).
Item 5.01 Changes in Control of Registrant Governance
A change in control of the company occurred, such as through a merger, takeover, or management buyout.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Merger consideration per share $127.00 per share Cash consideration for each eligible common share
Total merger consideration Approximately $5.4 billion Total consideration payable in connection with the merger
Initial term loans $2.1 billion Provided for under the new credit agreement
Revolving credit loans Up to $350 million Maximum aggregate principal amount outstanding under the new credit agreement
2028 notes outstanding $116.284 million As of November 17, 2026
2030 notes outstanding $1 billion As of November 17, 2026
2028 notes conversion amount Approximately $1,491.08 per $1,000 principal amount During the Make-Whole Fundamental Change Period
2030 notes conversion amount Approximately $1,029.25 per $1,000 principal amount During the Make-Whole Fundamental Change Period
Make-Whole Fundamental Change Period financial
"during the Make-Whole Fundamental Change Period"
Conversion Rate financial
"will be entitled to an increased Conversion Rate"
Conversion rate is the proportion of items, people or contracts that take a desired action out of the total possible — for example the share of website visitors who make a purchase, or the number of convertible bonds that are exchanged for shares. Investors care because it measures how effectively a business or financial instrument turns opportunity into real outcomes, like sales or share issuance, which directly affects revenue, cash flow and ownership dilution.
Fundamental Change Repurchase Price financial
"maximum Fundamental Change Repurchase Price for each series"
Capped Call Transactions financial
"termination of the Capped Call Transactions"
Capped call transactions are agreements where investors buy options that give them the chance to benefit if a stock's price goes up, but with a limit on how much they can gain. This helps protect them from paying too much if the stock's price rises a lot, similar to having a maximum limit on a reward. They matter because they help investors manage risk while still allowing some upside potential.
swingline loans financial
"swingline loans in an aggregate principal amount"
A swingline loan is a very short-term, on-demand loan that sits inside a larger credit facility to cover immediate cash needs like payroll, small bills, or last-minute payments. Think of it as an emergency overdraft from a lender: it’s quick to draw, repaid fast, and usually carries faster fees, so investors watch it as a signal of a company’s liquidity pressure and potential cost or covenant stress.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did ITGR shareholders receive in the merger?

Each outstanding common share, except shares owned by Parent, Merger Sub or Parent subsidiaries, converted into a right to receive $127.00 in cash, without interest. Integer reported approximately $5.4 billion in total merger consideration.

Can ITGR noteholders require the company to repurchase their notes because of the merger?

No. Holders do not have the right to require repurchase of the 2028 or 2030 notes in connection with the merger, and Integer will not make an offer to repurchase them. The notes remain subject to the merger-related conversion rights described for the applicable conversion period.

What else does ITGR’s new credit agreement permit?

In addition to initial term loans and revolving credit loans, the agreement permits letters of credit with an aggregate stated amount of up to $87.5 million outstanding and swingline loans of up to $75 million outstanding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false --12-31 0001114483 0001114483 2026-11-17 2026-11-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

____________________________

 

FORM 8-K

____________________________

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported):  November 17, 2026

 

 

INTEGER HOLDINGS CORPORATION
(Exact name of registrant as specified in its charter)

____________________________

 

Delaware   1-16137   16-1531026
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

5830 Granite Parkway, Suite 1150   Plano, Texas   75024
(Address of principal executive offices)   (Zip Code)

 

(214) 618-5243
Registrant’s telephone number, including area code

____________________________

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.001 par value per share   ITGR   New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

INTRODUCTORY NOTE

 

This Current Report on Form 8-K is being filed in connection with the completion on November 17, 2026 (the “Closing Date”) of the previously announced acquisition by Armstrong Parent, Inc., a Delaware corporation (“Parent”), of Integer Holdings Corporation, a Delaware corporation (“Integer” or the “Company”), pursuant to the Agreement and Plan of Merger (the “Merger Agreement,” and the transactions contemplated thereby, the “Transaction”), dated as of August 2, 2026, by and among Integer, Parent and Armstrong Bidco, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”).

 

Pursuant to the Merger Agreement, and upon the terms and conditions therein, on the Closing Date, Merger Sub merged with and into Integer and Integer continued as the surviving corporation and wholly owned subsidiary of Parent (the “Merger”). Parent and Merger Sub are each affiliates of investment funds managed by Kohlberg Kravis Roberts & Co. L.P., a leading global investment firm.

 

Item 1.01  Entry into a Material Definitive Agreement

 

The information set forth in the Introductory Note to this Current Report on Form 8-K (the “Introductory Note”) is incorporated into this Item 1.01 by reference.

 

Financing; New Credit Agreement

 

On the Closing Date, Parent, as holdings (in such capacity, “Holdings”), Merger Sub, as the initial borrower (in such capacity, the “Initial Borrower”), and the Company (immediately following the consummation of the Merger, as successor to the Initial Borrower, the “Borrower”) entered into that certain Credit Agreement with Citibank, N.A., as administrative agent and collateral agent, and the lenders and letter of credit issuers from time to time party thereto (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”). The Credit Agreement provides for extensions of credit in the form of (i) initial term loans to the Borrower in an aggregate principal amount of $2,100,000,000 (the “Initial Term Loans”), (ii) revolving credit loans made available to the Borrower at any time and from time to time in an aggregate principal amount at any time outstanding not to exceed $350,000,000 (including letter of credit extensions and swingline loans, described below), (iii) letters of credit from time to time in an aggregate stated amount at any time outstanding not to exceed $87,500,000, and (iv) swingline loans in an aggregate principal amount at any time outstanding not to exceed $75,000,000. The obligations under the Credit Agreement are guaranteed by Holdings and certain subsidiaries of the Borrower and are secured on a first priority basis by substantially all assets of the Borrower and the guarantors (in each case, subject to certain exclusions and exceptions). The Credit Agreement includes representations and warranties, covenants, events of default and other provisions that are customary for facilities of this type.

 

New Supplemental Indentures

 

On the Closing Date, the Company entered into (i) the First Supplemental Indenture, dated as of the Closing Date (the “2028 First Supplemental Indenture”), to the Indenture, dated as of February 3, 2023 (the “2028 Original Indenture” and, as amended by the 2028 First Supplemental Indenture, the “2028 Indenture”), by and between the Company and Wilmington Trust, National Association, a national banking association, as trustee (the “Trustee”), relating to the Company’s 2.125% Convertible Senior Notes due 2028 (the “2028 Notes”), and (ii) the First Supplemental Indenture, dated as of the Closing Date (the “2030 First Supplemental Indenture” and, together with the 2028 First Supplemental Indenture, the “Supplemental Indentures”), to the Indenture, dated as of March 18, 2025, by and between the Company and the Trustee (the “2030 Original Indenture” and, as amended by the 2030 First Supplemental Indenture, the “2030 Indenture”), relating to the Company’s 1.875% Convertible Senior Notes due 2030 (the “2030 Notes” and, together with the 2028 Notes, the “Notes”). The 2028 Original Indenture and the 2030 Original Indenture are referred to herein collectively as the “Original Indentures” and the 2028 Indenture and the 2030 Indenture are referred to herein collectively as the “Indentures.” As of the Closing Date, $116,284,000 aggregate principal amount of the 2028 Notes was outstanding and $1,000,000,000 aggregate principal amount of the 2030 Notes was outstanding.

  

 

 

As a result of the Merger, and pursuant to the 2028 First Supplemental Indenture and the 2030 First Supplemental Indenture, at and after the effective time of the Merger, the right to convert each $1,000 principal amount of Notes was changed into a right to convert such principal amount of Notes into units of Reference Property (as defined in the applicable Indenture), with each unit consisting solely of $127.00 in cash (an amount equal to the Merger Consideration (as defined below)). As a result, the consideration due upon conversion of each $1,000 principal amount of Notes for which the Conversion Date (as defined in the applicable Indenture) (occurs at or after the Effective Time (as defined below) will be solely cash in an amount equal to the applicable Conversion Rate (as defined in the applicable Indenture) in effect on the Conversion Date (as may be increased by any Additional Shares (as defined herein)), multiplied by $127.00.

 

The consummation of the Merger constitutes a Merger Event, a Fundamental Change and a Make-Whole Fundamental Change (each as defined in the applicable Indenture) under each Indenture. The effective date of the Merger Event, Fundamental Change and Make-Whole Fundamental Change in respect of the Notes is November 17, 2026 (the “Effective Date”).

  

The Supplemental Indentures also amend the Original Indentures, as applicable, to provide that (i) in the case of any Make-Whole Fundamental Change that also constitutes a Fundamental Change in respect of which the Company is not required to offer to repurchase, or to repurchase, the applicable Notes, the Make-Whole Fundamental Change Period (as defined in the applicable Indenture) will be the period from, and including, the effective date of such Make-Whole Fundamental Change to, and including, the earlier of (x) the close of business on the 35th Trading Day (as defined in the applicable Indenture) immediately following such effective date (or, if the Company gives notice to the holders of Notes of such transaction after such effective date, the 35th Trading Day immediately following the date of such notice) and (y) the close of business on the second Scheduled Trading Day (as defined in the applicable Indenture) immediately preceding the maturity date of the applicable Notes, and (ii) if a transaction constitutes a Fundamental Change in respect of which the Company is not required to offer to repurchase, or to repurchase, the applicable Notes, all or any portion of a holder’s applicable Notes may be surrendered for conversion at any time from, and including, the effective date of such transaction to, and including, the earlier of (x) the close of business on the 35th Trading Day immediately following such effective date (or, if the Company gives notice to the holders of Notes of such transaction after such effective date, the 35th Trading Day immediately following the date of such notice) and (y) the close of business on the second Scheduled Trading Day immediately preceding the maturity date of the applicable Notes.

  

The foregoing descriptions of the Indentures and the transactions contemplated thereby are subject to and qualified in their entirety by reference to the full text of the Indentures. A copy of the 2028 Original Indenture was filed as Exhibit 4.1 to the Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission (the “SEC”) on February 6, 2023, and a copy of the 2028 First Supplemental Indenture is filed as Exhibit 4.1 hereto. A copy of the 2030 Original Indenture was filed as Exhibit 4.1 to the Current Report on Form 8-K filed by the Company with the SEC on March 19, 2025, and a copy of the 2030 First Supplemental Indenture is filed as Exhibit 4.2 hereto. Each of the 2028 Original Indenture, 2030 Original Indenture and Supplemental Indentures is incorporated by reference into this Item 1.01. This Current Report on Form 8-K does not constitute an offer to tender for, or purchase, or a solicitation of an offer to tender for, or purchase, any of the Notes or any other security.

 

Item 1.02  Termination of a Material Definitive Agreement

 

The information set forth in the Introductory Note is incorporated into this Item 1.02 by reference.

 

Termination of Existing Credit Agreement

 

In connection with the consummation of the Merger, on the Closing Date, the Company repaid in full all outstanding obligations under the Credit Agreement, dated as of September 2, 2021 (as amended, restated, supplemented or otherwise modified from time to time, the “Existing Credit Agreement”), by and among the Company, as parent, Greatbatch Ltd., as borrower, Wells Fargo Bank, National Association, as administrative agent, and the other agents and lenders party thereto, and terminated all commitments thereunder. Upon such repayment, all obligations under the Existing Credit Agreement, other than certain continuing indemnity obligations, were released, satisfied and discharged in full and all security interests in the collateral securing the loans were automatically terminated, released, satisfied and discharged.

 

Termination of Capped Call Transactions

 

On January 31, 2023, in connection with the pricing of the 2028 Notes, the Company entered into capped call transactions (the “2028 Base Capped Call Transactions”) with certain financial institutions (collectively, the “2028 Capped Call Counterparties”). On February 1, 2023, in connection with the exercise of the option to purchase additional 2028 Notes by the initial purchasers of the 2028 Notes, the Company entered into additional capped call transactions with the 2028 Capped Call Counterparties (the “Additional 2028 Capped Call Transactions” and, together with the 2028 Base Capped Call Transactions, the “2028 Capped Call Transactions”).

  

 

 

On March 13, 2025, in connection with the pricing of the 2030 Notes, the Company entered into capped call transactions (the “2030 Base Capped Call Transactions”) with certain financial institutions (collectively, the “2030 Capped Call Counterparties”). On March 14, 2025, in connection with the exercise of the option to purchase additional 2030 Notes by the initial purchasers of the 2030 Notes, the Company entered into additional capped call transactions with the 2030 Capped Call Counterparties (the “Additional 2030 Capped Call Transactions” and, together with the 2030 Base Capped Call Transactions, the “2030 Capped Call Transactions”). Each of the 2028 Capped Call Counterparties and 2030 Capped Call Counterparties is referred to herein as a “Capped Call Counterparty” and, collectively, as the “Capped Call Counterparties,” and the 2028 Capped Call Transactions and the 2030 Capped Call Transactions are referred to herein collectively as the “Capped Call Transactions.”

 

In connection with the Merger, the Company entered into a termination agreement with each Capped Call Counterparty (each, a “Termination Agreement” and, collectively, the “Termination Agreements”) pursuant to which the Capped Call Transactions with such Capped Call Counterparty terminated upon the closing of the Merger in exchange for an agreed-upon cash payment from such Capped Call Counterparty payable within one business day following the closing of the Merger.

 

The foregoing description of the termination of the Capped Call Transactions is subject to and qualified in its entirety by reference to the full text of the Termination Agreements. A copy of the form of Termination Agreement is filed as Exhibit 10.1 hereto and is incorporated into this Item 1.02 by reference.

 

Item 2.01  Completion of Acquisition or Disposition of Assets

 

The information set forth in the Introductory Note is incorporated herein by reference.

 

Pursuant to the Merger Agreement, at the effective time of the Merger (the “Effective Time”), each share of Company common stock, par value $0.001 per share (the “Company Common Shares”), outstanding immediately before the Effective Time (other than Company Common Shares owned by Parent, Merger Sub or any other subsidiary of Parent) was converted into the right to receive $127.00 in cash (the “Merger Consideration”).

 

With respect to equity awards of the Company that were outstanding as of immediately prior to the Effective Time, at the Effective Time, such awards were generally treated as follows:

 

·RSU Awards: Each restricted stock unit (“RSU”) award that was vested or vested upon the Transaction in accordance with its terms was canceled and converted into the right to receive a cash amount equal to (i) the number of Company Common Shares subject to such RSU award, multiplied by (ii) the Merger Consideration. Each unvested RSU award was canceled and converted into a cash amount equal to (a) the number of Company Common Shares subject to such RSU award, multiplied by (b) the Merger Consideration, 50% of which will be paid as soon as practicable after the Effective Time (assessed on a tranche-by-tranche basis) and the remaining 50% of which will be paid subject to satisfaction of the same vesting conditions that applied to the corresponding RSU award, with vesting protections upon a qualifying termination of employment.

 

 

 

·PSU Awards: Each performance stock unit (“PSU”) award for which the performance period was completed but that had not yet been settled was canceled and converted into the right to receive a cash amount equal to (i) the number of Company Common Shares subject to such PSU award based on actual performance, multiplied by (ii) the Merger Consideration. Each PSU award for which the performance period was not completed was canceled and converted into a cash amount equal to (a) the number of Company Common Shares subject to such PSU award based on the greater of (x) target performance and (y) actual performance, multiplied by (b) the Merger Consideration, 50% of which will be paid as soon as practicable after the Effective Time (assessed on a tranche-by-tranche basis) and the remaining 50% of which will be paid subject to satisfaction of the same service vesting conditions (without regard to any performance conditions) that applied to the corresponding PSU award, with vesting protections upon a qualifying termination of employment.  

 

·Options: Each option to purchase Company Common Shares (“Company Option”) was fully vested and converted into the right to receive a cash amount equal to (i) the excess, if any, of the Merger Consideration over the applicable exercise price per Company Common Share subject to such award of Company Options, multiplied by (ii) the number of Company Common Shares subject to such Company Option. If the exercise price of the Company Option was equal or greater to the Merger Consideration, such Company Option was cancelled for no consideration.

 

The foregoing summary of the Transaction does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Merger Agreement, a copy of which was attached as Exhibit 2.1 to the Current Report on Form 8-K filed by the Company with the SEC on August 4, 2026 and is incorporated by reference as Exhibit 2.1 to this Current Report on Form 8-K, which is incorporated by reference herein.

 

 

 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

 

The information set forth in the Introductory Note and under Item 2.01 of this Current Report on Form 8-K is incorporated into this Item 3.01 by reference.

 

In connection with the consummation of the Merger, the Company requested that the New York Stock Exchange (“NYSE”) suspend trading of the Company Common Shares effective prior to the opening of trading on the Closing Date. On the Closing Date, following the Effective Time, the Company notified NYSE that the Merger had been consummated and requested that NYSE file a Form 25 Notification of Removal from Listing and/or Registration with the SEC to remove the Company Common Shares from listing on NYSE and deregister the Company Common Shares under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). As a result, trading of the Company Common Shares was suspended prior to the opening of trading on the Closing Date.

 

Upon effectiveness of the Form 25, the Company intends to file a Certification and Notice of Termination on Form 15 with the SEC to deregister the Company Common Shares under Section 12(g) of the Exchange Act and suspend the Company’s reporting obligations under Sections 13 and 15(d) of the Exchange Act.

 

Item 3.03  Material Modifications to Rights of Security Holders

 

The information set forth in the Introductory Note, Item 2.01, Item 3.01, Item 5.01 and Item 5.03 of this Current Report on Form 8-K is incorporated into this Item 3.03 by reference.

 

At the Effective Time, each holder of Company Common Shares as of immediately prior to the Effective Time ceased to have any rights as a shareholder of the Company other than the right to receive the Merger Consideration pursuant to the Merger Agreement.

 

Item 5.01  Changes in Control of Registrant

 

The information set forth in the Introductory Note, Item 2.01, Item 3.01, Item 3.03, Item 5.02 and Item 5.03 is incorporated into this Item 5.01 by reference.

 

As a result of the Merger, at the Effective Time, a change of control of the Company occurred, and the Company became a wholly owned subsidiary of Parent. The total consideration payable in connection with the Merger and pursuant to the Merger Agreement is approximately $5,400,000,000. The funds used by Parent to consummate the Merger and complete the related transactions came from debt and equity financing, together with cash on hand.

 

Item 5.02  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

The information set forth in the Introductory Note and Item 2.01 of this Current Report on Form 8-K is incorporated into this Item 5.02 by reference.

 

As of the Effective Time, in connection with the consummation of the Merger, all of the members of the board of directors of the Company (the “Board”) resigned as directors of the Company and from any committees of the Board of which they were members. These resignations were not a result of any disagreement between the Company and such directors on any matter relating to the Company’s operations, policies or practices. Pursuant to the Merger Agreement, immediately after the Effective Time, the directors of Merger Sub as of the Effective Time, Max Lin and Hunter Craig, became the directors of the surviving corporation.

 

Also, pursuant to the Merger Agreement, the incumbent officers of the Company immediately prior to the Effective Time continued as officers of the surviving corporation immediately after the Effective Time.

 

Item 5.03  Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

 

The information set forth in the Introductory Note and Item 2.01 of this Current Report on Form 8-K is incorporated into this Item 5.03 by reference.

 

Effective upon completion of the Merger, pursuant to the Merger Agreement, the Company’s certificate of incorporation and bylaws were amended and restated in their entirety. Copies of the Company’s amended and restated certificate of incorporation and amended and restated bylaws are attached as Exhibits 3.1 and 3.2, respectively, hereto and are incorporated herein by reference.

 

Item 7.01  Regulation FD Disclosure

 

The Merger constitutes a Merger Event, a Fundamental Change and a Make-Whole Fundamental Change under the Indentures, effective as of the Effective Date.

  

 

 

Pursuant to the Indentures, holders may surrender all or any portion of their Notes for conversion at any time from or after the Effective Date until the close of business (5:00 p.m. New York City time) on January 8, 2027, the 35th Trading Day after the Effective Date (such period, the “Conversion Period”). The cash consideration due upon conversion of each $1,000 in principal amount of Notes will be equal to the applicable Conversion Rate in effect on the relevant Conversion Date (as may be increased by any additional shares pursuant to Section 14.03 of the applicable Indenture (“Additional Shares”)) for each of the 2028 Notes and 2030 Notes, multiplied by the Merger Consideration of $127.00 per share.

 

The Conversion Rate for the 2028 Notes for which the relevant notice of conversion is received by the conversion agent during the period which begins on, and includes, the Effective Date and ends at the close of business (5:00 p.m. New York City time) on January 8, 2027, the 35th Trading Day after the Effective Date (the “Make-Whole Fundamental Change Period”), will be increased by 0.2734 Additional Shares per $1,000 principal amount of 2028 Notes, to a total Conversion Rate of 11.7408 per $1,000 principal amount of 2028 Notes. Accordingly, a holder of 2028 Notes whose notice of conversion is received by the conversion agent during the Make-Whole Fundamental Change Period will receive cash in the amount of approximately $1,491.08 per $1,000 principal amount of 2028 Notes converted, less any applicable withholding taxes.

 

The Conversion Rate for the 2030 Notes for which the relevant notice of conversion is received by the conversion agent during the Make-Whole Fundamental Change Period will be increased by 1.4800 Additional Shares per $1,000 principal amount of 2030 Notes, to a total Conversion Rate of 8.1043 per $1,000 principal amount of 2030 Notes. Accordingly, a holder of 2030 Notes whose notice of conversion is received by the conversion agent during the Make-Whole Fundamental Change Period will receive cash in the amount of approximately $1,029.25 per $1,000 principal amount of 2030 Notes converted, less any applicable withholding taxes.

 

A notice of conversion received after the close of business (5:00 p.m. New York City time) on January 8, 2027 will not be entitled to the Additional Shares and will instead be subject to the base Conversion Rate per $1,000 principal amount of each of the 2028 Notes and 2030 Notes, which is 11.4681 and 6.6243, respectively.

 

Holders do not have the right to require the Company to repurchase their Notes in connection with the Merger. The Indentures provide that the Company is not required to offer to repurchase, or to repurchase, the Notes in respect of a Fundamental Change (i) that constitutes a Merger Event for which the Reference Property consists entirely of cash in U.S. dollars; (ii) pursuant to which, immediately after the consummation of such transaction or event, the Notes become convertible into consideration that consists solely of cash in U.S. dollars in an amount per $1,000 in principal amount of Notes that equals or exceeds the Fundamental Change Repurchase Price (as defined in the applicable Indenture) per $1,000 in principal amount of Notes (calculated assuming that such amount includes the maximum amount of accrued but unpaid interest payable as part of the Fundamental Change Repurchase Price for such transaction or event); and (iii) in respect of which the Company timely sends the notice of such Fundamental Change, as required pursuant to the Indentures. Each of the foregoing conditions has been satisfied with respect to each of the 2028 Notes and the 2030 Notes. Accordingly, the Company is not making, and will not make, any offer to repurchase the Notes, and will not repurchase any Notes, in connection with the Merger. Any Fundamental Change Repurchase Notice (as defined in the applicable Indenture) delivered by a holder will be of no effect.

 

On November 17, 2026, the Company provided holders of the 2028 Notes and the 2030 Notes with notices of the applicable Supplemental Indenture, Make-Whole Fundamental Change, Fundamental Change and right to convert pursuant to the applicable Indenture.

 

On November 17, 2026, the Company issued a press release providing notice of the Effective Date of a Make-Whole Fundamental Change, Fundamental Change and right to convert pursuant to each of the Indentures. A copy of the press release is attached hereto as Exhibit 99.1.

 

On November 17, 2026, the Company issued a press release announcing consummation of the transaction between the Company and Parent. A copy of the press release is attached hereto as Exhibit 99.2.

 

The information included in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 and Exhibit 99.2 attached hereto, is being furnished and shall not be deemed to be filed for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

  

 

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits

 

  No. Document Description
  2.1+^ Agreement and Plan of Merger, by and among Integer Holdings Corporation, Armstrong Parent, Inc. and Armstrong Bidco, Inc., dated as of August 2, 2026 (incorporated herein by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K, initially filed with the SEC on August 4, 2026)
  3.1 Amended and Restated Certificate of Incorporation of Integer Holdings Corporation
  3.2 Amended and Restated Bylaws of Integer Holdings Corporation
  4.1 2028 Notes First Supplemental Indenture, dated November 17, 2026, by and between Integer Holdings Corporation and Wilmington Trust, National Association, as trustee
  4.2 2030 Notes First Supplemental Indenture, dated November 17, 2026, by and between Integer Holdings Corporation and Wilmington Trust, National Association, as trustee
  10.1 Form of Termination Agreement (2028 Notes), between Integer Holdings Corporation and the applicable Capped Call Counterparty
  10.2 Form of Termination Agreement (2030 Notes), between Integer Holdings Corporation and the applicable Capped Call Counterparty
  99.1 Press release, dated November 17, 2026
  99.2 Press release, dated November 17, 2026
  104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

+ In accordance with Item 601(a)(5) of Regulation S-K, certain schedules to this agreement have been omitted (as marked by asterisks).

 

^ In accordance with Item 601(b)(2) of Regulation S-K, portions of the exhibit have been omitted because it is both not material and is of the type the registrant treats as private or confidential.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date:  November 17, 2026 /s/ Lindsay K. Blackwood
  Name: Lindsay K. Blackwood
  Title: General Counsel & Secretary

 

 

 

Exhibit 99.1

 

FOR IMMEDIATE RELEASE

 

 

 

Integer Holdings Corporation Provides Notice of

Make-Whole Fundamental Change, Fundamental Change and Right to Convert to

Holders of its 2.125% Convertible Senior Notes due 2028 and

1.875% Convertible Senior Notes due 2030 in Connection with Completed Merger

 

PLANO, Texas, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (“Integer” or the “Company”), a leading medical device contract development and manufacturing organization, today delivered notices (each, a “Notice” and together, the “Notices”) to holders of its 2.125% Convertible Senior Notes due 2028 (the “2028 Notes”) and its 1.875% Convertible Senior Notes due 2030 (the “2030 Notes” and, together with the 2028 Notes, the “Notes”), pursuant to the Indenture, dated as of February 3, 2023, governing the 2028 Notes, and the Indenture, dated as of March 18, 2025, governing the 2030 Notes (each, an “Indenture”), in each case between the Company and Wilmington Trust, National Association, as trustee (the “Trustee”), that a Make-Whole Fundamental Change and a Fundamental Change (each as defined in the applicable Indenture) occurred under each Indenture on November 17, 2026 (the “Effective Date”).

 

On the Effective Date, the Company completed its previously announced merger (the “Merger”) with Armstrong Bidco, Inc., a wholly owned subsidiary of Armstrong Parent, Inc. (“Parent”), pursuant to the Agreement and Plan of Merger, dated as of August 2, 2026. As a result of the Merger, the Company became a wholly owned subsidiary of Parent, and each outstanding share of the Company’s common stock (other than certain excluded shares) was converted into the right to receive $127.00 in cash, without interest (the “Merger Consideration”).

 

Notice of Make-Whole Fundamental Change Effective Date

 

Pursuant to each Indenture, holders may convert their Notes in connection with the Merger at any time from, and including, the Effective Date to, and including, the close of business (5:00 p.m., New York City time) on January 8, 2027, which is the thirty-fifth (35th) Trading Day immediately following the Effective Date (the “Conversion Period”). Holders whose Notice of Conversion is received by the conversion agent during the period from, and including, the Effective Date to, and including, 5:00 p.m., New York City time, on January 8, 2027 (the “Make-Whole Fundamental Change Period”), will be entitled to an increased Conversion Rate, as follows:

 

2028 Notes. The consideration due upon conversion during the Make-Whole Fundamental Change Period will be cash of approximately $1,491.08 per $1,000 principal amount of 2028 Notes, based on a Conversion Rate of 11.7408 (the Conversion Rate of 11.4681 in effect immediately prior to the Merger, plus 0.2727 Additional Shares), multiplied by $127.00. A holder whose Notice of Conversion is received after the Make-Whole Fundamental Change Period ends will receive cash of $1,456.45 per $1,000 principal amount of 2028 Notes.

 

 

 

2030 Notes. The consideration due upon conversion during the Make-Whole Fundamental Change Period will be cash of approximately $1,029.25 per $1,000 principal amount of 2030 Notes, based on a Conversion Rate of 8.1043 (the Conversion Rate of 6.6243 in effect immediately prior to the Merger, plus 1.4800 Additional Shares), multiplied by $127.00. A holder whose Notice of Conversion is received after the Make-Whole Fundamental Change Period ends will receive cash of $841.29 per $1,000 principal amount of 2030 Notes.

 

Upon the expiration of the Make-Whole Fundamental Change Period, the Conversion Rate for each series of Notes will automatically, without further notice, return to the Conversion Rate in effect immediately prior to the Merger. After the Conversion Period ends, the Notes will no longer be convertible solely on account of the Merger and will be convertible only under the circumstances and during the periods set forth in the applicable Indenture.

 

Notice of Fundamental Change; No Repurchase Right

 

Under Section 15.02(e) of each Indenture, the Company is not required to offer to repurchase, or to repurchase, the Notes in connection with the Merger, because the Merger is a Merger Event for which the Reference Property consists solely of cash in U.S. dollars, the cash amount into which the Notes became convertible immediately after the Merger equals or exceeds the maximum Fundamental Change Repurchase Price for each series, and the Company has timely delivered the required notice. Accordingly, holders do not have the right to require the Company to repurchase their Notes in connection with the Merger.

 

Holders of Notes should read the applicable Notice carefully, as it contains important information regarding the procedures and timing for the exercise of conversion rights. The Notices are available through The Depository Trust Company or by requesting a copy from Wilmington Trust, National Association, which is serving as the conversion agent, at:

 

Wilmington Trust, National Association

1310 Silas Deane Highway

Wethersfield, CT 06109

Attn: Integer Holdings Corporation Notes Administrator

 

None of the Company, Parent, their respective boards of directors or employees, or the Trustee has made or is making any representation or recommendation to any holder as to whether to convert or refrain from converting its Notes.

 

This press release is for informational purposes only and is not an offer to purchase, or a solicitation of an offer to sell, any securities, nor shall there be any purchase or sale of securities in any state or jurisdiction in which such offer, solicitation, purchase or sale would be unlawful.

 

About Integer®

 

Integer Holdings Corporation is one of the largest medical device contract development and manufacturing organizations (CDMOs) in the world, serving the cardio and vascular, neuromodulation, and cardiac rhythm management markets. As a strategic partner of choice, we advance the goals of our medical device customers through industry-leading engineering and manufacturing, with a relentless commitment to quality, service, and innovation. The company’s brands include Greatbatch Medical® and Lake Region Medical®. Additional information is available at www.integer.net.

 

Investor Relations:

 

Kristen Stewart

kristen.stewart@integer.net

551-337-3973

 

 

 

 

Exhibit 99.2 

 

 

   
   

 

Integer Announces Completion of Acquisition by KKR  

~ Positioned to Advance Innovation and Growth in Support of Customers and Patients ~

 

 

PLANO, Texas, November 17, 2026 (GLOBE NEWSWIRE) – Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading global medical device contract development and manufacturing organization (CDMO), today announced the completion of its acquisition by an affiliate of investment funds managed by KKR, a leading global investment firm, in a transaction valued at an enterprise value of approximately $5.7 billion (the “Transaction”).

 

The Transaction was announced on August 3, 2026, and was approved by Integer stockholders on October 21, 2026. Under the terms of the Transaction, Integer stockholders will receive $127 per share in cash. With the completion of the Transaction, Integer’s common stock has ceased trading and will no longer be listed on the New York Stock Exchange.

 

“Today marks an exciting new chapter for Integer, our associates, customers, and the patients we collectively serve,” said Payman Khales, Integer’s President and CEO. “Integer has built a reputation as a trusted partner to the world’s leading medical device companies and emerging innovators through our relentless focus on quality, customer service, and innovation. Together with KKR, we are well positioned to accelerate our growth strategy, further invest in our people, capabilities and technologies, and continue delivering the expertise and solutions that help our customers bring life-enhancing and life-saving devices to patients around the world.”

 

“We are pleased to officially welcome Integer to the KKR portfolio and look forward to building on the Company’s strong foundation alongside Payman and the management team,” said Max Lin, Partner at KKR. “We see significant opportunities to leverage our resources and expertise to support Integer’s next phase of growth, expand its capabilities and strengthen its position as a trusted partner to the global medical device industry.”

 

About Integer®

 

Integer Holdings Corporation is one of the largest medical device contract development and manufacturing organizations (CDMOs) in the world, serving the cardio and vascular, neuromodulation, and cardiac rhythm management markets. As a strategic partner of choice, we advance the goals of our medical device customers through industry-leading engineering and manufacturing, with a relentless commitment to quality, service, and innovation. The Company’s brands include Greatbatch Medical® and Lake Region Medical®. Additional information is available at www.integer.net.

 

 

 

About KKR

 

KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com. For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group’s website at www.globalatlantic.com.

 

Contacts 

Integer 

Media Relations: 

Misty Tippen 

misty.tippen@integer.net

469-536-6702

 

Investor Relations: 

Kristen Stewart 

kristen.stewart@integer.net

551-337-3973

 

KKR 

Media:
media@kkr.com

 

 

 

Cautionary Statement Regarding Forward-Looking Statements

 

Some of the statements contained in this communication and other written and oral statements made from time to time by us and our representatives are not statements of historical or current fact. As such, they are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby under the Private Securities Litigation Reform Act of 1995. We have based these forward-looking statements on our current expectations, and these statements are subject to known and unknown risks, uncertainties and assumptions. Forward-looking statements include, but are not limited to, statements relating to: potential litigation relating to the Transaction that has been or could be instituted against the parties to the Transaction, or their respective directors, managers, or officers, including the effects of any outcomes related thereto; our goals, plans, and strategic initiatives; long-term growth prospects; other events, conditions or developments that will or may occur in the future; and the timing of any of the foregoing. You can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “projects,” “forecast,” “outlook,” “assume,” “potential” or “continue” or variations or the negative counterparts of these terms or other comparable terminology. These statements are only predictions and are not guarantees of future performance, and investors should not place undue reliance on forward-looking statements as predictive of future results. Actual events or results may differ materially from those stated or implied by these forward-looking statements. In evaluating these statements and our prospects, you should carefully consider the factors set forth below. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary factors and by others contained throughout this communication.

 

Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements regarding the Transaction. All such forward-looking statements are based upon current plans, estimates, expectations, opportunities and ambitions that are subject to risks, uncertainties, assumptions, and other important factors, many of which are beyond the control of the Company, that could cause actual results to differ materially from those expressed in such forward-looking statements. Key factors that could cause actual results to differ materially include, but are not limited to, risks related to disruption of management time from ongoing business operations due to the Transaction; the risk that the Transaction could have an adverse effect on the parties’ business relationships and business generally, including the ability of the Company to retain customers and retain and hire key personnel and maintain relationships with their suppliers and customers, and on their operating results and businesses generally; the risk of unforeseen or unknown liabilities; customer, regulatory and other stakeholder approvals and support; the risk of unexpected future capital expenditures; the risk of potential litigation relating to the Transaction that has been or could be instituted against the Company or its directors and/or officers; the risk associated with third-party contracts containing material consent, anti-assignment, transfer or other provisions that may be related to the Transaction which are not waived or otherwise satisfactorily resolved; significant costs, or expenses incurred in connection with the Transaction; the risk of various events that could disrupt operations, including pandemics, epidemics or other public health crises or severe weather (such as droughts, floods, avalanches and earthquakes), cybersecurity attacks, security threats and governmental response to them, and technological changes; the risks of labor disputes, changes in labor costs and labor difficulties; and the risks resulting from other effects of industry, market, economic, legal or legislative, political or regulatory conditions outside of the Company’s control. All such factors are difficult to predict and are beyond our control, including those detailed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, which was filed with the Securities and Exchange Commission (the “SEC”) on February 23, 2026, the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended October 2, 2026, which was filed with the SEC on October 29, 2026, the Company’s definitive proxy statement filed with the SEC on September 14, 2026, as supplemented, and other documents subsequently filed by the Company with the SEC. The Company’s forward-looking statements are based on assumptions that the Company believes to be reasonable but that may not prove to be accurate. Other unpredictable factors not discussed in this communication could also have material adverse effects on forward-looking statements. The Company does not assume an obligation to update any forward-looking statements, except as required by applicable law. These forward-looking statements speak only as of the date hereof.

 

 

Filing Exhibits & Attachments

12 documents

Keep reading